Objective: To study the efficacy of colonoscopic crush cytology as a convenient and near-accurate method to evaluate colonic neoplasms. Study Design: Retrospective and cross-sectional. The original cytologic diagnoses were correlated with a histology report on 100 cases sent to the cytology laboratory over 2 years. Results: Of the 100 cases, 25 were nonmalignant. Of the 75 malignant lesions, 72 could be identified as positive for malignancy on cytology. The false-positives consisted of 6 adenomas and 1 case of ulcerative colitis. Thus, sensitivity and specificity of cytology are 96 and 63.2%, respectively. Of the 6 adenomas diagnosed as malignant, 4 showed high-grade dysplasia, and the other 2 showed superficial ulceration with low-grade dysplasia on histopathology. The ulcerative colitis case showed widespread ulcers and regenerative/reparative features on biopsy. The 3 adenocarcinomas diagnosed s benign on cytology showed an occasional malignant cell with thickened nuclear borders and prominent central nucleoli. Conclusions: With careful attention to the cytomorphology, coupled with good clinical and endoscopic correlation, crush cytology of the large intestine is a reliable diagnostic tool. It categorizes lesions as malignant and benign with a high sensitivity, positive predictive value, and negative predictive value. Adenomas and reparative/regenerative changes seen in inflammatory bowel disease are major pitfalls in the cytology diagnosis of malignancy that may be averted by informing the endoscopic findings and clinical history. Cytology diagnosis saves time and gives proper feedback to the gastroenterologist.

Keywords:
Colonic adenocarcinoma, Adenoma, Ulcerative colitis, Crush cytology
1.
Fenoglio-Preiser CM, Noffsinger AE, Stemmerman GN, Lantz PE, Isaacon PG: Epithelial neoplasms of the colon; in: Gastrointestinal Pathology: An Atlas and Text, ed 3. Philadelphia, Lippincot Williams & Wilkins, 2008, pp 899–1036.
2.
Jemal A, Center M, DeSantis C, Ward E: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prevent 2010; 19: 1893–1907.
3.
Rana S: Prevalence of gastrointestinal cancers in India; in Gandhi V, Mehta K, Grover R, Pathak S, Aggarwal B (eds): Multi-Targeted Approach to Treatment of Cancer. Basel, Springer, 2015, pp 217–231.
4.
Edwards B, Ward E, Kohler B, Eheman C, Zauber A, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA: Annual Report to the Nation on the Status of Cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116: 544–573.
5.
Winawer S, Sherlock P, Hajdu S: The role of upper gastrointestinal endoscopy in patients with cancer. Cancer 1976; 37: 440–448.
6.
Winawer S, Leinder S, Hajdu S, Sherlock P: Colonoscopic biopsy and cytology in the diagnosis of colon cancer. Cancer 1978; 42: 2849–2853.
7.
Conrad R, Prabhu SC, Cobb C, Raza A: Role of cytopathology in the diagnosis and management of gastrointestinal tract cancers. J Gastrointest Oncol 2012; 3: 285–298.
8.
Bosman FT, Carneiro F, Hruban RH, Thiese ND: WHO classification of tumors of the colon and rectum; in Bosman FT, Carneiro F, Hruban Rh, Thiese ND (eds): WHO Classification of Tumors of the Digestive System, ed 4. Lyon, IARC, 2010, p 132.
9.
Rosai J: Gastrointestinal tract-large bowel; in Rosai J (ed): Rosai and Ackerman’s Surgical Pathology, ed 10. Philadelphia, Mosby Elsevier, 2011, pp 731–802.
10.
Bibbo M, Keebler CM: Alimentary tract; in Bibbo M, Wilbur D (eds): Comprehensive Cytopathology. Philadelphia, Elsevier, 2015, pp 59–64.
11.
Brouwer R, MacDonald A, Matthews R, Gunn J, Monson J, Hartley J: Brush cytology for the diagnosis of colorectal cancer. Dis Colon Rectum 2009; 52: 598–601.
12.
Yu G, Nayar R, Furth E: Adenocarcinoma in colonic brushing cytology: high-grade dysplasia as a diagnostic pitfall. Diagn Cytopathol 2001; 24: 364–368.
13.
Greenson JK, Odze RD: Inflammatory disorders of the large intestine; in Odze RD, Goldblum JR (eds): Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas, ed 2. Philadelphia, Saunders, 2009, pp 355–394.
14.
Cooper HS: Intestinal neoplasms; in Mills SE (ed): Sternberg’s Diagnostic Surgical Pathology, ed 6. Philadelphia, Wolters Kluwer Health, 2015, pp 1522–1540.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.